Preoperative apolipoprotein B/A1 ratio is an independent prognostic factor in metastatic renal cell carcinoma

Kidney cancer is among the 10 most common human malignancies in men and women [1,2]. According to statistics, approximately 65,340 new cases and 14,970 deaths are related to this malignancy in 2018 in the United States [3]. Renal cell carcinoma (RCC), which is derived from renal tubular epithelial cells, is the most common histological type and accounts for over 80% of all cases [1,2,4,5]. Approximately more than 15% of all RCC patients are diagnosed with metastatic renal cell carcinoma (mRCC) [1,3,6], and over 20% of patients with localized RCCs have metastases after partial or radical nephrectomy [7].
Source: Urologic Oncology: Seminars and Original Investigations - Category: Urology & Nephrology Authors: Source Type: research